Soleno’s rare pediatric disease drug faces PDUFA delay by three monthsnews2024-11-26T16:02:30+00:00November 26th, 2024|Endpoints News|
Bristol Myers reveals more job cuts in New Jerseynews2024-11-25T20:09:52+00:00November 25th, 2024|Endpoints News|
Minnesota 340B revenue driven by hospitals and high-priced drugs, first state report saysnews2024-11-25T19:14:09+00:00November 25th, 2024|Endpoints News|
Merck halts Phase 3 trial with PAH drug Winrevair following positive interim data news2024-11-25T17:32:47+00:00November 25th, 2024|Endpoints News|
Gilead buys experimental HIV vaccines from a small Barcelona biotechnews2024-11-25T13:41:20+00:00November 25th, 2024|Endpoints News|
AstraZeneca’s Truqap edges closer to prostate cancer label expansion with Phase 3 winnews2024-11-25T11:57:13+00:00November 25th, 2024|Endpoints News|
Trump picks former congressman and vaccine injury advocate to lead CDCnews2024-11-23T03:08:59+00:00November 23rd, 2024|Endpoints News|
FDA approves BridgeBio’s heart disease drug, setting up competition with Pfizer, Alnylamnews2024-11-23T00:15:53+00:00November 23rd, 2024|Endpoints News|
Sanofi introduces new 340B payment model — reportnews2024-11-22T20:00:19+00:00November 22nd, 2024|Endpoints News|
Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compoundersnews2024-11-22T19:58:06+00:00November 22nd, 2024|Endpoints News|
